The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 6, 2008, Pages 1112-1116

  Berrisford, Richard G ^a   Wong, Wei Lup ^b   Day, David ^a   Toy, Elizabeth ^a   Napier, Mark ^a   Mitchell, Keith ^a   Wajed, Saj ^a  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^b Paul Strickland Scanner Centre   (United Kingdom)

Author keywords

Lymph nodes; Neoplasm staging; Oesophageal neoplasm; Oesophagogastric junction neoplasm; Positron emission tomography; Prospective studies

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; THORACOSCOPY; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; DECISION MAKING; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT CARE TEAM; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 43049168916     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.01.055     Document Type: Article

References (22)

1. Blazeby J.M., Farndon J.R., Donovan J., and Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88 (2000) 1781-1787
2. Medical Research Council Working Group on oesophageal cancer. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
3. Ott K., Weber W., and Siewert J.R. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19 (2006) 433-442
4. Erasmus J.J., and Munden R.F. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol 17 (2007) 29-37
5. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., Scarffe J.H., Lofts F.J., Falk S.J., Iveson T.J., Smith D.B., Langley R.E., Verma M., Weeden S., Chua Y.J., and Magic T.P. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
6. Luketich J.D., Schauer P.R., Christie N.A., Weigel T.L., Raja S., Fernando H.C., Keenan R.J., and Nguyen N.T. Minimally invasive esophagectomy. Ann Thorac Surg 70 (2000) 906-911
7. Luketich J.D., velo-Rivera M., Buenaventura P.O., Christie N.A., McCaughan J.S., Litle V.R., Schauer P.R., Close J.M., and Fernando H.C. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238 (2003) 486-494
8. Flamen P., Lerut A., Van C.E., De W.W., Peeters M., Stroobants S., Dupont P., Bormans G., Hiele M., De L.P., Van R.D., Coosemans W., Ectors N., Haustermans K., and Mortelmans L. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
9. Liberale G., Van Laethem J.L., Gay F., Goldman S., Nagy N., Coppens E., Gelin M., and El N.I. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol 30 (2004) 942-947
10. van Westreenen H.L., Heeren P.A., van Dullemen H.M., van der Jagt E.J., Jager P.L., Groen H., and Plukker J.T. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 9 (2005) 54-61
11. Flanagan F.L., Dehdashti F., Siegel B.A., Trask D.D., Sundaresan S.R., Patterson G.A., and Cooper J.D. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168 (1997) 417-424
12. Luketich J.D., Friedman D.M., Weigel T.L., Meehan M.A., Keenan R.J., Townsend D.W., and Meltzer C.C. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68 (1999) 1133-1136
13. Weber W.A., and Ott K. Imaging of esophageal and gastric cancer. Semin Oncol 31 (2004) 530-541
14. Lowe V.J., Booya F., Fletcher J.G., Nathan M., Jensen E., Mullan B., Rohren E., Wiersema M.J., Vazquez-Sequeiros E., Murray J.A., Allen M.S., Levy M.J., and Clain J.E. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7 (2005) 422-430
15. Rice T.W. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 10 (2000) 471-485
16. Lerut T., Flamen P., Ectors N., Van C.E., Peeters M., Hiele M., De W.W., Coosemans W., Decker G., De L.P., Deneffe G., Van R.D., and Mortelmans L. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232 (2000) 743-752
17. Kneist W., Schreckenberger M., Bartenstein P., Grunwald F., Oberholzer K., and Junginger T. Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?. World J Surg 27 (2003) 1105-1112
18. Heeren P.A., Jager P.L., Bongaerts F., van D.H., Sluiter W., and Plukker J.T. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 45 (2004) 980-987
19. van Westreenen H.L., Westerterp M., Bossuyt P.M., Pruim J., Sloof G.W., van Lanschot J.J., Groen H., and Plukker J.T. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 (2004) 3805-3812
20. Chao K.S. Functional imaging for early prediction of response to chemoradiotherapy: 3′-deoxy-3′-(18)F-fluorothymidine positron emission tomography - a clinical application model of esophageal cancer. Semin Oncol 33 Suppl 11 (2006) 59-63
21. Munden R.F., Macapinlac H.A., and Erasmus J.J. Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging 21 (2006) 137-145
22. Price T., Waters J., Cunningham D., Norman A., Hill M., Scarffe H., Harper P., Nicolson M., Seymour M., Hickish T., Iveson T., and Oates J. Palliative chemotherapy in oesophageal carcinoma: evidence for clinical benefit. Proc Am Soc Clin Oncol (2000) 19 (abstr 1228)